iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding iTeos Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 81 | 83 | +2 |
| Shares | 30.1M | 29.5M | −620.1K (−2.1%) |
| Value | $1.03B | $755.8M | −$272.5M (−26.5%) |
New holders (22)
Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (20)
Institutions that held iTeos Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Cowen and Company, LLC | 588,238 | $20.1M |
| Ally Bridge Group (NY) LLC | 322,794 | $11.0M |
| PFM Health Sciences, LP | 232,216 | $7.94M |
| J. Goldman & Co LP | 42,110 | $1.44M |
| Swiss National Bank | 27,700 | $947.0K |
| Rafferty Asset Management, LLC | 27,221 | $930.0K |
| California Public Employees Retirement System | 21,700 | $742.0K |
| HighVista Strategies LLC | 19,804 | $677.0K |
| STRS Ohio | 14,300 | $488.0K |
| Atom Investors LP | 11,261 | $385.0K |
| Jane Street Group, LLC | 11,148 | $381.0K |
| Credit Suisse AG | 8,912 | $304.0K |
| D. E. Shaw & Co., Inc. | 7,742 | $265.0K |
| Athanor Capital, LP | 6,480 | $221.0K |
| SG Americas Securities, LLC | 4,244 | $145.0K |
| Great West Life Assurance Co | 929 | $31.0K |
| Pacer Advisors, Inc. | 640 | $22.0K |
| Bank of Montreal | 685 | $21.0K |
| The PNC Financial Services Group, Inc. | 5 | $0 |
| Parallel Advisors, LLC | 5 | $0 |